CASI icon

CASI Pharmaceuticals
CASI

Overview Fund Activity

30 hedge funds and large institutions have $5.66M invested in CASI Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.

Holders
30
Holders Change
+3
Holders Change %
+11.11%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SM
1
Sabby Management
Florida
$2.21M
2
VKH
2
Virtu KCG Holdings
New York
$25K
3
EHC
3
Everett Harris & Co
California
$17K
4
GC
4
Guggenheim Capital
Illinois
$17K
5
CLOS
5
Compagnie Lombard Odier SCmA
Switzerland
$10K

Top Sellers

1
WSCM
1
Wellington Shields Capital Management
New York
$1.21M
2
MHP
2
Manatuck Hill Partners
Connecticut
$0
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$573K
4
EEG
4
E.E. Geduld
$25K
5
U
5
UBS
Switzerland
$0
Name Market Value Shares Shares
Change 		Shares
Change %
U
26
UBS
Switzerland
– – -4,024 Closed
US Bancorp
27
US Bancorp
Minnesota
– – -272 Closed
Deutsche Bank
28
Deutsche Bank
Germany
– – -244 Closed
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$0 145 -19 -12%
Wells Fargo
30
Wells Fargo
California
$0 62 – –
CFA
31
Carroll Financial Associates
North Carolina
$0 9 – –
Bank of Montreal
32
Bank of Montreal
Ontario, Canada
$0 36 – –
KTC
33
Kistler-Tiffany Companies
Pennsylvania
$0 45 – –
FWM
34
Focused Wealth Management
New York
$0 45 +45 New
1
2